COMMUNIQUÉS West-GlobeNewswire

Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations
17/11/2025
LITS Is the First and Only US Publicly Traded Company to Gain Institutional Exposure to LTC, Holding 929,548 LTC Tokens SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or [...]
JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System
17/11/2025
IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its 1,000th commercial [...]
Ohio State’s Center for Psychedelic Drug Research and Education collaborates with MAPS for the Ohio P.E.A.C.E. program
17/11/2025
Using funding provided by the Ohio Department of Behavioral Health, the Center for Psychedelic Drug Research and Education (CPDRE) will equip more than 127,000 Ohio professionals with skills in psychedelic harm [...]
Corza Medical Launches SensorTek™ ROP Kit: The First and Only Single-Use Kit with Integrated Lens for Retinopathy of Prematurity Exams
17/11/2025
Launch Coincides with World Prematurity Day 2025, Advancing Care for the Most Vulnerable Patients BOULDER, Colo., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Corza Medical , a global medical technology company, today announced [...]
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
17/11/2025
CHICAGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today reported financial results for the [...]
Positron Corporation Announces Its Transition to a Reporting SEC Company
17/11/2025
Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become a reporting [...]
FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
17/11/2025
FDA grants Fast Track designation to DPTX3186, Dewpoint’s first in class condensate modulator for gastric cancer Designation provides increased FDA engagement, rolling review eligibility, and potential for accelerated [...]
Vital Nutrients Releases Clinical Findings Showing Plant-Based Cortisol Balance Improves Sleep, Mood, and Stress Response
17/11/2025
MIDDLETOWN, Conn., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Vital Nutrients , a leading practitioner-founded nutritional supplement company, has released new research highlighting the potential benefits of Cortisol Balance , a [...]
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections
17/11/2025
Five-year grant of $7 million annually to the academic researchers is aimed at accelerating the development of new therapeutics to combat resistant fungal infections, including the Company’s next generation of [...]
Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease
17/11/2025
-- STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- Positive efficacy [...]
CFO Tania Micki to leave Tecan for new role in 2026
17/11/2025
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, November 17, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief [...]
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
17/11/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX ® System both in clinics and homes ARC- [...]
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies
17/11/2025
Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician- [...]
James M. O’Brien Appointed Chief Financial Officer at Mesoblast
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME PHARMA ANNONCE AVOIR REÇU DES ACCORDS DE PRINCIPE POUR PROLONGER CERTAINS ACCORDS D'OBLIGATIONS Berlin, Allemagne, le 17 novembre 2025, 8h00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany , November 17, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology [...]
Nxera Announces Focused Restructuring to Enhance Path to Profitability
17/11/2025
Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announced a focused restructuring designed to concentrate investment and resources on [...]
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
17/11/2025
Daix (France), New York City (New York, États-Unis), le 17 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]

Pages